This was originally published on Greystone.Net's blog, GreyMatters, on May 19. The past four years, Kyruus has conducted a survey of 1,000 healthcare consumers to understand how they search for, select, and schedule appointments with healthcare providers. While the most recent report revealed early signs that the COVID-19 pandemic was changing consumer preferences for accessing care, a year into the pandemic we wanted to poll consumers again to gain a deeper understanding of its impact on their decision making.
Last week, the CDC reported that over 40% (142M) of Americans had received at least one dose and 30% (98M) had been fully vaccinated. While this is certainly worth celebrating, particularly as numbers continue to rise, it is worth digging into how these numbers are rising across demographics and in particular, races. For example, of those who reported their race/ethnicity to the CDC*, nearly two-thirds were White (65%), 11% were Hispanic, 8% were Black, 5% were Asian, 1% were American Indian or Alaska Native, and <1% were Native Hawaiian or Other Pacific Islander. Additionally, 9% reported multiple or “other.”
This blog was originally published on AWS.com on April 21. The last few months have brought a lot of highs: the approval of multiple COVID-19 vaccines, the vaccination of more than 86 million Americans, and an overall decline in cases nationally. At Kyruus, we have celebrated the success of our health system customers in facilitating vaccine access, who through our partnership, have scheduled over 400,000 vaccine appointments.
Last month, we invited Mike Dozier, VP Chief Information Officer at Ochsner Lafayette General, and Chris Castellano, VP of Customer Experience Channels at Banner Health, for a discussion on using the vaccine rollout to rebuild consumer relationships.
An interview with Sean Michaels, Vice President of IT Operations & Service Delivery at Health First, a not-for-profit integrated delivery network (IDN) serving Central Florida. The IDN includes health insurance plans, four hospitals, a multi-specialty medical group, and outpatient and wellness services.
With both the Pfizer and Moderna COVID-19 vaccines approved and vaccine distribution occurring across the country, for the first time in months, there is a sense of optimism about returning to some type of normalcy. However, before we can enter a period of recovery or our “new normal,” one thing stands in the way. Vaccinating the public. While many healthcare organizations have spent the last several months rapidly innovating their operations and access models to meet the demands of pandemic (e.g., COVID-19 testing, delivering care virtually, etc.), distributing the COVID-19 vaccine represents a new and even more complex challenge.